News
Lilly’s oral diabetes pill shows potential for blood sugar control and weight loss in global trial
The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FACES, talks with Michael See, MS, CDCES, ACSM-CEP, NBC-HWC, about tips for exercise for people living with diabetes. Weiner: ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results